Replies to post #188169 on Biotech Values

[jbog]

Abbv could get Enanta for $1.5B (the amount of penalties Gonzales paid for his failed tax adventure).

It has crossed my mind why Abbvie hasn't made a move on Enta. Maybe they value things differently than we expect.